Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression. | Cancer Immunol Immunother | 2024 | 38175205 | PubTator, text mining | PubMed |
| VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk. | Int J Biol Sci | 2024 | 38169627 | PubTator, text mining | PubMed |
| Genome-wide association studies for economically important traits in mink using copy number variation. | Sci Rep | 2024 | 38167844 | PubTator, text mining | PubMed |
| Integrative genotyping of cancer and immune phenotypes by long-read sequencing. | Nat Commun | 2024 | 38167262 | PubTator, text mining | PubMed |
| TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia. | Histopathology | 2024 | 38087646 | PubTator, text mining | PubMed |
| Single-cell atlas reveals characteristic changes in intrahepatic HBV-specific leukocytes. | Microbiol Spectr | 2024 | 38032223 | PubTator, text mining | PubMed |
| A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis. | Blood Adv | 2024 | 37939259 | PubTator, text mining | PubMed |
| TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides. | J Cutan Pathol | 2024 | 37932931 | PubTator, text mining | PubMed |
| Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis. | J Autoimmun | 2024 | 37931332 | PubTator, text mining | PubMed |
| Peripheral helper T cells, mavericks of peripheral immune responses. | Int Immunol | 2024 | 37788648 | PubTator, text mining | PubMed |
| SCAR: Single-cell and Spatially-resolved Cancer Resources. | Nucleic Acids Res | 2024 | 37739405 | PubTator, text mining | PubMed |
| Thymocyte selection-associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway. | Hematol Oncol | 2024 | 37712442 | PubTator, text mining | PubMed |
| From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy. | Bioact Mater | 2024 | 37637082 | PubTator, text mining | PubMed |
| Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma. | Hepatology | 2024 | 37540187 | PubTator, text mining | PubMed |
| Comparative analysis of cell-cell communication at single-cell resolution. | Nat Biotechnol | 2024 | 37169965 | PubTator, text mining | PubMed |
| Seroprevalence of ToRCH Pathogens among Children Admitted to a Tertiary Care Hospital in Eastern India for Cataract Surgery and Cochlear Transplantation. | Curr Pediatr Rev | 2024 | 36809946 | PubTator, text mining | PubMed |
| Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity. | Front Immunol | 2023 | 38283365 | PubTator, text mining | PubMed |
| Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing. | Front Immunol | 2023 | 38283342 | PubTator, text mining | PubMed |
| Cellular Components of the Tumor Environment in Gliomas-What Do We Know Today? | Biomedicines | 2023 | 38275375 | PubTator, text mining | PubMed |
| NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma. | Contemp Oncol (Pozn) | 2023 | 38239867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=14